Controlled Release

Venue: Copthorne Tara Hotel

Location: London, United Kingdom

Event Date/Time: May 11, 2011 End Date/Time: May 12, 2011
Early Registration Date: May 28, 2011
Report as Spam


SMi’s 8th Controlled Release conference will showcase the fascinating work being done by both pharmaceutical and academic professionals in the areas of formulation, nanotechnology, manufacturing, a range of different therapeutics and will also cover a comprehensive variety of drug delivery approaches by focusing on oral, dermal, nasal, inhalatory and parenteral methods.

Tackling the legal landscape in controlled release intellectual property rights is a vital part of drug development, so ensure that you attend to be informed by Mr. Gerry Kamstra Partner, Partner, IP & Life Sciences, Bird and Bird, who will give advice on some of the most important considerations in this process.

Our expert speaker Lineup includes:

Dr. Didier Bazile, Global Head of Drug Delivery Technologies and Innovation, Sanofi-Aventis

Dr. Olivier Drap, Associate Director R&D Business Development, Pfizer

Dr. Andrew Bryant, Program Manager - Novel Drug Delivery Systems, Pfizer

Dr. Frank Thielmann, Senior Fellow PDU Inhalation, Novartis

Dr. Joel Richard, Senior Director, Head of Drug Product Development, IPSEN

Dr. Andreas Schatzlein, Reader in Cancer Pharmacology, School of Pharmacy, University of London

Professor Lisbeth Illum, CEO, Critical Pharmaceuticals Limited

Mr. Gerry Kamstra Partner, IP & Life Sciences, Bird and Bird

Dr. Hassan Mohammad, Principal Scientist, Mundipharma Research LTD

Dr. Mario Maio, Head of Formulation & Process Development Department, Merck Serono

Dr. Stefan Bassarab, Director, Pharmaceutical Development, Boehringer-Ingelheim


Additional Information

PLUS a pre-conference workshop on: Ocular Drug Delivery: Identifying Advances and Opportunities Held on 29th March 2011, Copthorne Tara Hotel Led by Dr. Hong Guo, Vice President of Research, pSivida